Well Professor Wright commented that the results were very positive and that BG was at least equivalent to the gold standard topical non-steroidal, very impressive. He then goes on to say that there is an opportunity for further development and evaluation over a longer time frame so I don't believe it is due to the irritation.
When i read this I immediately thought of the eye wand and how we were lead to believe that it was a hard launch (well at least I did anyway). If there are further tweaks will there be another clinical trial? Professor Wrights comments certainly doesn't sound like the BG product is sign sealed delivered, its rather perplexing. Will P&G sign on the dotted lines when Professor Wright says there is an opportunity to further develop the product?
- Forums
- ASX - By Stock
- WFL
- Ann: Bodyguard Results
Ann: Bodyguard Results, page-176
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online